Zobrazeno 1 - 3 of 3 pro vyhledávání: '"Barrios DG"'
2
Publisher Correction: Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein.
Autor: Milev MP; Department of Biology, Concordia University, Montreal, QC, Canada., Stanga D; Department of Biology, Concordia University, Montreal, QC, Canada., Schänzer A; Institute of Neuropathology, Justus Liebig University Giessen, Giessen, Germany., Nascimento A; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; U705 and U703 Center for Biomedical Research On Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Saint-Dic D; Department of Biology, Concordia University, Montreal, QC, Canada., Ortez C; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Natera-de Benito D; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Barrios DG; Servicio de Pediatría, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain., Colomer J; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Badosa C; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Jou C; U705 and U703 Center for Biomedical Research On Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Pathology Department and Biobank, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Gallano P; U705 and U703 Center for Biomedical Research On Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Servicio de Genética, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain., Gonzalez-Quereda L; U705 and U703 Center for Biomedical Research On Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Servicio de Genética, Hospital de La Santa Creu I Sant Pau, Barcelona, Spain., Töpf A; The John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK., Johnson K; The John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.; Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK., Straub V; The John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK., Hahn A; Department of Child Neurology, Justus Liebig University Giessen, Giessen, Germany. Andreas.Hahn@paediat.med.uni-giessen.de., Sacher M; Department of Biology, Concordia University, Montreal, QC, Canada. michael.sacher@concordia.ca.; Department of Anatomy and Cell Biology, McGill University, Montreal, QC, Canada. michael.sacher@concordia.ca., Jimenez-Mallebrera C; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain. cjimenezm@fsjd.org.; U705 and U703 Center for Biomedical Research On Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain. cjimenezm@fsjd.org.
Publikováno v: Scientific reports [Sci Rep] 2020 Nov 10; Vol. 10 (1), pp. 19770. Date of Electronic Publication: 2020 Nov 10.
Zobrazit plný text záznamu
3
Akademický článek
Characterization of three TRAPPC11 variants suggests a critical role for the extreme carboxy terminus of the protein.
Autor: Milev MP; Concordia University, Department of Biology, Montreal, Quebec, Canada., Stanga D; Concordia University, Department of Biology, Montreal, Quebec, Canada., Schänzer A; Institute of Neuropathology, Justus Liebig University Giessen, Giessen, Germany., Nascimento A; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain.; U705 and U703 Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Saint-Dic D; Concordia University, Department of Biology, Montreal, Quebec, Canada., Ortez C; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Natera-de Benito D; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Barrios DG; Servicio de Pediatría, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain., Colomer J; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Badosa C; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Jou C; U705 and U703 Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Pathology Department and Biobank, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain., Gallano P; U705 and U703 Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Servicio de Genética, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Gonzalez-Quereda L; U705 and U703 Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.; Servicio de Genética, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Töpf A; The John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK., Johnson K; The John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.; Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, UK., Straub V; The John Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK., Hahn A; Department of Child Neurology, Justus Liebig University Giessen, Giessen, Germany. Andreas.Hahn@paediat.med.uni-giessen.de., Sacher M; Concordia University, Department of Biology, Montreal, Quebec, Canada. michael.sacher@concordia.ca.; McGill University, Department of Anatomy and Cell Biology, Montreal, Quebec, Canada. michael.sacher@concordia.ca., Jimenez-Mallebrera C; Neuromuscular Unit, Neuropaediatrics Department, Hospital Sant Joan de Déu, Institut de Recerca Sant Joan de Déu, Barcelona, Spain. cjimenezm@fsjd.org.; U705 and U703 Center for Biomedical Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain. cjimenezm@fsjd.org.
Publikováno v: Scientific reports [Sci Rep] 2019 Oct 01; Vol. 9 (1), pp. 14036. Date of Electronic Publication: 2019 Oct 01.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje